With a new $20 million in funding, electronic stethoscope startup Eko wants to research your beating heart
It’s hard to compete against the Apple Watch or even an app on your phone when it comes to personal heart rate monitors these days. However, Eko, a startup best known for creating an electronic stethoscope to monitor your heart rhythm, hopes further research and development will help give its more clinically promoted device a leg up as a leader in the fight against heart disease.
To get there, the company recently closed on a $20 million round of Series B financing, led by Artis Ventures. New and returning investors in the round also include DigiTx Partners, NTT Venture Capital (NTTVC), 3M Ventures, Mayo Clinic, Seraph Group, and XTX Ventures.
On top of that, the company has teamed up with some well-known health partners such as the Mayo Clinic, Northwestern Medicine and Sutter Health, to further connect data points and screen patients using the Eko device.
It’s no leap to say technology has made great strides in cardiac care in the last decade. Today, we can use a number of devices to find out if there’s some sort of arrhythmia in a matter of seconds. However, choosing the way we do that is critical — getting the right information from trained professionals before jumping
This post was originally published on this site